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Background/aim: The aim of this study was to investigate the prevalence of virulence genes as well as patterns of antibiotic resistance
in cystitis and pyelonephritis uropathogenic Escherichia coli (UPEC) isolates.
Materials and methods: Two hundred UPEC isolates were collected from hospitalized patients with pyelonephritis (n = 50) and
cystitis (n = 150) in Shafa Hospital in Iran. Antimicrobial susceptibility and ESBL production were determined with confirmatory tests.
Polymerase chain reaction assay was performed to determine the prevalence of virulence genes in UPEC strains.
Results: Of a total 200 UPEC isolates, the highest and lowest resistance rates to antibiotics were for cephalexin (74%) and nitrofurantoin
(9%), respectively. Of these isolates, 72 (36%) and 128 (64%) strains were ESBL-positive and ESBL-negative, respectively. The frequency
of fimH, papC, and hly was 64%, 38%, and 12%, respectively. The most commonly identified virulence gene in ESBL-positive and ESBLnegative strains was fimH 46 (23%) and 86 (43%), respectively. The hlyA gene was more prevalent among patients with pyelonephritis
than cystitis.
Conclusion: The frequency of virulence genes was not significantly different between pyelonephritis and cystitis UPEC strains in the
studied patients, but the prevalence rates of hlyA and papC genes were higher among UPEC strains isolated from inpatients compared
to outpatients; hence, they could be considered as useful targets for prophylactic interventions.
Key words: Urinary tract infections, Escherichia coli, antimicrobial resistance, virulence genes, cystitis, pyelonephritis

1. Introduction
Urinary tract infections (UTIs), including cystitis and
pyelonephritis, are among the most common infections in
humans, primarily caused by uropathogenic Escherichia
coli (UPEC) (1,2). The severity of the infection varies
depending on the virulence of the infecting bacteria and
host susceptibility (3–5). Urinary tract infections often
occur in patients with anatomically and functionally normal
urinary tracts (3). In ascending infections, colonization
of microorganisms in the urethra leads to the upward
spread of bacteria to the kidneys (causing pyelonephritis)
or bladder (causing cystitis) (2,6). Antibiotic resistance is
another serious problem in infections caused by UPEC.
Extended-spectrum beta-lactamases (ESBL) are enzymes
that confer resistance to most beta-lactam antibiotics,
including penicillins, cephalosporins, and aztreonam (7).
The high antimicrobial resistance of UPEC associated with

ESBL production significantly reduces the therapeutic
options and increases the treatment costs and mortality
rates (8–10). ESBL-producing UPEC strains, which are
increasing in prevalence worldwide, have an appreciable
deleterious impact on the clinical management of UTIs (11).
UPEC strains harbor a great number of genes that encode
different virulence factors, which contribute to greater
pathogenicity (11,12). Virulence factors of UPEC strains
have a significant role in the development of UTIs (13). The
molecular features and functions of these virulence factors
have been determined (1,14). The most likely theory is that
UPEC primarily germinate from nonpathogenic strains by
acquiring new virulence genes (through DNA horizontal
transfer of plasmids, bacteriophages, transposons, and
pathogenicity islands located at chromosomal loci), which
confer an increased ability to adapt to new niches and
allow the bacteria to increase the ability to cause a broad
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spectrum of diseases (3,15). The dominant virulence
factors facilitate colonization and invasion of the bacteria
in sites such as the urethra, as well as the toxin that affects
the host cells (16,17). The UPEC strains possess adherence
and virulence factors on the surface called pili or fimbriae,
which mediate the attachment to uroepithelial cells and
successfully initiate infections (18). Specific attachment
is facilitated by bacterial proteins called adhesins, which
may be associated with fimbriae (19). The pyelonephritisassociated pilus (Pap) operon is the most commonly found,
encoding P fimbriae (20). As the main attachment factors,
P fimbriae are essentially associated with pyelonephritis
infection (2). The papC gene, located on the pap operon,
is among the most important virulence genes associated
with adhesion in UPEC strains (21). Another virulence
factor associated with adhesion that has important roles
in the development of UTIs is FimH (adhesive subunit of
type 1 fimbriae) (13). FimH is a mannose-specific adhesin
located on the tip of type 1 fimbriae of Escherichia coli and
is capable of mediating shear-enhanced bacterial adhesion.
Among adhesins of UPEC, FimH is a major determinant
that has a high tropism for urinary tract receptors;
thus, adhesion factor FimH is important in colonizing
different niches of UPEC isolates (13,22). Besides bacterial
adherence, several virulence factors may contribute to the
pathogenicity of UPEC strains, including the production
of hemolysin toxin (15). A-hemolysin (HlyA) is the most
significant secretory virulence factor, which is encoded
by the hly gene (18). The characterization of virulence
genes can be useful to improve our understanding of the
pathogenesis of UTIs and to minimize the complications,
including kidney failure. Few studies have been conducted
to detect the prevalence of virulence genes in UPEC strains
causing distinct types of UTIs in our region. Therefore, the
present study was proposed to determine the frequency
of important virulence genes as well as the patterns of
antibiotic resistance and ESBL production in UPEC strains
isolated from patients with cystitis and pyelonephritis in
Tehran, Iran.
2. Material and methods
2.1. Study design and bacteria collection
In this study, a total of two hundred nonduplicate E.
coli strains were isolated from 4650 urine samples of
patients suffering from UTI symptoms who referred
to the laboratories of hospitals over a period of 2 years.
Bacteriological and biochemical tests were performed
for confirmation of E. coli strains. Samples with over
100,000 Cfu/ml E. coli count from clean-voided urine were
defined as positive UTI infections. Cytobacteriological
examination of urine specimens was the basis for the
diagnosis of cystitis and pyelonephritis among patients.
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2.2. Antibacterial susceptibility testing
The antibiotic susceptibility of E. coli was determined using
the Kirby–Bauer disk diffusion method on Muller Hinton
agar medium with cefotaxime (30 µg), ceftazidime (30 µg),
nalidixic acid (30 µg), trimethoprim-sulfamethoxazole
(12.5/23.75 µg), amikacin (30 µg), ciprofloxacin (5 µg),
gentamicin (10 µg), and nitrofurantoin (30 µg). The
obtained results of the tests were interpreted according to
the guidelines of the Clinical Laboratory Standards Institute
(23). E. coli ATCC 25922 and Klebsiella pneumoniae ATCC
700603 strains were used as negative and positive controls,
respectively.
2.3. Determination of extended-spectrum beta-lactamase phenotype
The presence of the beta-lactamase phenotype was
determined by combination disk diffusion method (24).
Based on this test, after the inoculation of bacteria in
standard concentrations on Muller Hinton agar medium,
a disk of ceftazidime (30 µg) alone and a combination
disk containing ceftazidime and clavulanic acid (30
µg/10 µg) were placed at a distance of 25 mm from each
other. Increase in the size of inhibition zone around the
combination disk compared to the ceftazidime disk alone
equal to or above 5 mm was considered as positive ESBL
phenotype.
2.4. DNA extraction and PCR assay
The colonies of E. coli strains grown on agar medium
were suspended in TE buffer and total genomic DNA
for amplification was purified from whole cells by simple
boiling method (25). The purity and integrity of extracted
DNA was confirmed by electrophoresis and biophotometer
analysis, respectively. The PCR amplification was
performed for the investigation of three types of virulence
genes including papC, fimH, and hlyA with specific
primers as labeled in Table 1. The PCR products were
electrophoresed on agarose gel and visualized by gel
documentation after ethidium bromide staining.
2.5. Statistical analysis
Statistical analysis was performed using SPSS 16.0 (SPSS
Inc., Chicago, IL, USA). Correlation between variables was
evaluated by chi-square test. P < 0.05 was considered as
statistically significant.
3. Results
A total of 200 E. coli isolates were recovered from urine
samples with a count of more than 105 cfu/mL during
2015–2017. Frequency of E. coli isolation was higher in
females (86%) than males (14%). Ages of the patients
suffering from UTIs ranged between 1 and 91 years. The
median age was 38 ± 22.7 years. The number of E. coli
isolates recovered from inpatient and outpatients was 40
(20%) and 160 (80%), respectively. Among the 200 E. coli
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strains, 72 (36%) strains revealed the ESBL phenotype. Of
72 positive ESBL strains, 24 (12%) and 48 (24%) strains
were isolated from pyelonephritis and cystitis cases,
respectively. PCR products of three virulence genes were
analyzed on agarose gel (Figure). Results showed that the
frequency of the studied virulence genes including papC,
fimH, and hlyA were 38%, 64%, and 12%, respectively. The
frequency of carrying any of these three virulence genes
alone was 32% for fimH, 4% for hlyA, and 4% for papC.
The fimH gene was the most common virulence gene and
was detected in 64% of patients, which further revealed
that the prevalence was higher in cystitis cases (65.3%).
Twenty-four percent of isolates were negative for these
three virulence genes (Table 2). The majority of virulence
genes were detected in ESBL and non-ESBL isolates and
in outpatients and inpatients. The hlyA, papC, and fimH

genes were respectively present in 10 (31.25%), 15 (46.8%),
and 21 (65.6%) of strains isolated from inpatients and 16
(9.5%), 62 (36.9%), and 108 (64.2%) of strains collected
from outpatients. The incidences of fimH, papC, and hlyA
virulence genes were higher in inpatients compared to
outpatients. There was a significant difference between
ESBL-positive and -negative groups for carrying the three
virulence genes (P < 0.005). The virulence genes were
most frequently detected in patients with ESBL-positive
strains and the fimH gene was the most prevalent. The
composition of the virulence genes was similar in both
sexes. The prevalence of virulence genes was higher
in patients over 50 years of age (Table 3). Multidrug
resistance was detected by antibiotic susceptibility test.
Of the 200 isolates, 128 (64%) were multidrug-resistant.
In ESBL-producing E. coli strains, 100% of strains had

Table 1. Primer sequences of studied virulence genes in E. coli isolates.
Primer

Oligonucleotides

Product size

Reference

papC

F: GTGGCAGTATGAGTAATGACCGTTA
R: ATATCCTTTCTGCAGGGATGCAATA

200 bp

(39)

fimH

F: TGCAGAACGGATAAGCCGTGG
R: GCAGTCACCTGCCCTCCGGTA

508 bp

(39)

hlyA

F: AACAAGGATAAGCACTGTTCTGGCT
R: ACCATATAAGCGGTCATTCCCGTCA

1177 bp

(39)

F: Forward primer, R: reverse primer.

Figure. Gel electrophoresis of PCR products. A) PCR products of hlyA gene (1117 bp), B) PCR products
of fimH gene (500 bp), C) PCR products of papC gene (200 bp).
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Table 2. Different patterns of virulence factors among UPEC
isolates.
Pattern

Rate

EC1 (none of the genes)

24%

EC2 (hlyA)

4%

EC3 (fimH)

32%

EC4 (papC)

4%

EC5 (hlyA-papC)

4%

EC6 (hlyA-fimH)

0%

EC7 (papC-fimH)

28%

EC8 (papC-fimH-hlyA)

4%

multidrug resistance, while in E. coli strains without ESBL
production 43.75% were multidrug-resistant (P < 0.005)
(Table 4). There was a significant difference in antibiotic
resistance between patients suffering from pyelonephritis
and cystitis (P < 0.001).
4. Discussion
UTIs caused by uropathogenic Escherichia coli are among
the most important infectious diseases leading to renal
failure (26). The degree of pathogenicity of UPEC strains is
dependent upon the existence of virulence genes (27,28).

Pyelonephritis-associated pilus (pap) is an important
factor in the pathogenesis of UTIs, and the essential role of
P fimbriae in the progress of pyelonephritis is well known
(2,29). The frequency of papC in our study was 38%. The
study of López-Banda et al. also reported a high frequency
of the papC gene (62%) in UPEC strains (21). The frequency
of the papC gene in UPEC isolates in the present study
was similar to those found in Iran, Brazil, Tunisia, and
China (6,8,30,31). The high prevalence of the papC gene
suggests that these strains have the ability to colonize the
kidneys and generate pyelonephritis. Our study showed
that the frequency of the papC gene between patients with
cystitis (36.6%) and pyelonephritis (36%) was similar. Our
findings are in disagreement with the results reported by
Firoozeh et al. (2) and Mabbett et al. (32), showing the pap
gene to be significantly more prevalent among patients
with pyelonephritis than cystitis. hlyA (α-hemolysin) has
been associated with clinical severity in UTI patients (33).
In our study, hlyA was detected in 12% of UPEC strains.
Jalali et al. (3) showed a higher frequency of the hlyA
gene (47%), while López-Banda et al. (21) indicated a
lower prevalence of this gene (7.4%) in UPEC strains. Our
results showed a higher prevalence of the hlyA gene among
UPEC isolates causing cystitis (10.6%) in comparison to
the isolates causing pyelonephritis (16%), while, in the
study of Firoozeh et al. (2), the frequency of hlyA was
1.3% and 6.9% in cystitis and pyelonephritis isolates,

Table 4. Antibiotic resistance rates in ESBL-positive and -negative isolates.
Antibiotic

ESBL-positive

ESBL-negative

R

I

S

R

I

S

FM

11.11%

-

88.89%

7.8%

1%

92.2%

GM

36.11%

2%

63.89%

25%

1%

75%

SXT

75%

-

25%

43.75%

-

56.25%

NA

75%

-

25%

54.68%

1%

45.32%

CP

52.7%

-

47.3%

18.75%

-

81.28%

CN

94.4%

-

5.6%

62.5%

1%

37.5%

CAZ

100%

-

-

-

-

-

Table 3. Prevalence of virulence genes among different statuses of patients.
Virulence
genes

Inpatients
(n = 32 )

Outpatients
(n = 168)

ESBL-positive
(n = 72)

ESBL-negative
(n = 128)

Cystitis
(n = 150)

pyelonephritis
(n = 50 )

Male
(n = 28)

Female
(n = 172)

hlyA

9.52%

25%

4.1%

7.1%

10.6%

16%

11.1%

12.79%

fimH

62.5%

64.28%

30.5%

32.8%

65.3%

60%

65.11%

57.14%

papC

43.75%

36.90%

20.8%

17.96%

36.6%

36%

21.4%

40.69%
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respectively. These findings show that the prevalence of
these genes possibly varies based on geographical region.
fimH, the adhesive subunit of type 1 fimbriae, was the most
prevalent virulence factor detected in UPEC strains. Also,
in agreement with our observation, Yun et al. (33), Jalali
et al. (3), Qin et al. (6), Tarchouna et al. (30), Tajbakhsh
et al. (34), and Wang et al. (35) found the fimH gene to be
the most prevalent virulence factor among UPEC strains.
In the study of Qin et al. (6), among 70 UPEC strains
fimH was detected in 82% and 88% of pyelonephritis and
cystitis specimens, respectively. Consistently, our findings
indicated that this prevalence was 60% and 65.3% in
pyelonephritis and cystitis specimens, respectively.
Our results showed that the prevalence of hlyA, papC,
and fimH genes in strains isolated from inpatients were
31.25%, 46.8%, and 65.6%, respectively, and in strains
collected from outpatients were 9.5%, 36.9%, and 64.2%,
respectively. In comparison to our findings, Santo et
al. (36) showed a similar frequency of hlyA (32%) but
no similar prevalence of pap (9%) and fimH (5%) was
reported in inpatient UPEC isolates; on the other hand,
a similar rate of pap (23%) and conflicting rates of hlyA
(64%) and fimH (20%) were observed in outpatients. Santo
et al. (36) illustrated that strains isolated from outpatients
displayed a greater number of virulence factors compared
to those from hospitalized subjects, in disagreement with
our results showing a higher frequency of fimH, papC, and
hlyA virulence genes in inpatients compared to outpatients.
In the study of Hojati et al. (13), from 130 fimH-positive
isolates, 47.7% and 52.3% belonged to inpatients and
outpatients, respectively, in agreement with our findings
representing a high prevalence of fimH in inpatient and
outpatient UPEC isolates. Mohajeri et al. (19) showed that
the frequency of the pap gene in inpatient and outpatient
subjects was 18.3% and 21.6%, respectively, which was
meaningfully lower than our results of the frequency of
this gene in inpatient and outpatient groups. Mohajeri et
al. (19) also indicated that the prevalence of the hemolysin
gene was 18.3% and 32.1% in inpatient and outpatient
subjects, respectively, contrary to our study indicating a
higher frequency of hlyA gene in inpatients compared to
outpatients.
In our study, out of 200 UPEC strains, 36% were
ESBL-positive and 64% were ESBL-negative. Similar to
our results, Tabar et al. (37) reported that 26.6% of UPEC
strains harbored ESBL-associated genes. Among these
isolates, 128 (64%) strains were multidrug-resistant. Tabasi
et al. (14) found that 26.9% of UPEC strains were ESBL
producers and totally 79% of all isolates were multidrugresistant, similar to our results for ESBL production and
multidrug resistance status among UPEC strains. Tabasi
et al. (14) also showed that antibiotic resistance occurred

at a higher rate among ESBL-producing isolates compared
to non-ESBL-producing strains for all tested antibiotics,
consistent with our results illustrating a higher rate
of resistance to different antibiotics in ESBL-positive
compared to ESBL-negative strains. In the study of Qin et
al. (6), 53% of UPEC isolates produced ESBL. On the other
hand, Qi et al. (38) reported that 2.9% of UPEC strains
recovered from outpatient urine cultures harbored ESBLs,
while in our study a higher number of UPEC strains
collected from outpatients harbored ESBL enzymes. Qin et
al. (6) declared that, among all studied virulence genes, the
fimH gene had the highest frequency in ESBL-producing
(76%) and non-ESBL-producing (97%) UPEC strains, in
agreement with the present research indicating the fimH
gene as the most frequent virulence gene detected in
ESBL-producing and non-ESBL-producing UPEC isolates.
However, the frequency of this gene was higher in ESBLpositive than ESBL-negative strains in our study.
Our study on UPEC strains isolated from pyelonephritis
and cystitis was meant as a step towards improving the
knowledge regarding their virulence gene determinants
and the ability to deal with them. In conclusion, in
our patients, we found no significant differences in
pyelonephritis-causing UPEC strains and cystitis-causing
UPEC strains in the presence of the studied virulence
genes, but the frequencies of hlyA and papC were higher
among UPEC strains isolated from inpatients compared
to outpatients; hence, they could be considered as useful
targets for prophylactic interventions. These findings raise
the possibility that the increase in virulence genes may
lead to the higher risk of severe diseases in inpatients. On
the other hand, our results indicated that about 64% of
UPEC isolates harbored the fimH gene. The high binding
ability of fimH could result in the increased pathogenicity
of UPEC strains; thus, this gene could be used as a possible
diagnostic marker and/or vaccine candidate. Also, in the
current study, higher resistance was observed in ESBLproducing strains than non-ESBL-producing strains;
therefore, empiric treatment regimens have to be modified
against ESBL enzymes to reach better therapeutic
outcomes.
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